RBM4B inhibitors are a class of chemical compounds that specifically target and inhibit the function of RBM4B, a member of the RNA-binding motif (RBM) protein family. RBM4B plays an important role in post-transcriptional regulation, particularly in alternative splicing, mRNA stability, and translation. As an RNA-binding protein, RBM4B contains RNA recognition motifs (RRMs) that enable it to interact with pre-mRNA and influence the inclusion or exclusion of specific exons during mRNA splicing. This regulation is essential for generating the diverse protein isoforms required for various cellular processes. RBM4B is also implicated in the control of mRNA translation, influencing the production of proteins from mRNA templates. Inhibitors of RBM4B function by binding to its RNA-binding domains or disrupting its interactions with other components of the splicing machinery, effectively blocking its ability to regulate RNA processing.
The inhibition of RBM4B can lead to significant alterations in gene expression, particularly in processes where alternative splicing is crucial for cellular differentiation and function. By preventing RBM4B from binding to its target mRNA sequences, these inhibitors disrupt normal splicing patterns, potentially leading to changes in protein isoform production. This disruption can impact a variety of biological processes, including cellular growth, differentiation, and tissue-specific functions. Researchers use RBM4B inhibitors to study the precise role of this protein in regulating splicing and post-transcriptional gene expression, providing valuable insights into how RNA-binding proteins control mRNA processing. Additionally, RBM4B inhibitors are useful tools for exploring the broader mechanisms of RNA regulation and understanding how alterations in splicing can affect cellular behavior. Studying these inhibitors contributes to the broader understanding of the complex networks that govern gene expression at the post-transcriptional level, offering insights into how RNA-binding proteins like RBM4B help maintain cellular function and respond to changing biological conditions.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $88.00 $200.00 | 13 | |
Triptolide is known to inhibit RNA polymerase II, which could lead to a decrease in the transcription of many genes, including potentially RBM4B. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine is a nucleoside analog that inhibits DNA methyltransferase, possibly leading to the reactivation of silenced genes or alteration of gene expression. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
Trichostatin A is a histone deacetylase inhibitor, which can lead to changes in chromatin structure and affect gene expression. | ||||||
DRB | 53-85-0 | sc-200581 sc-200581A sc-200581B sc-200581C | 10 mg 50 mg 100 mg 250 mg | $42.00 $185.00 $310.00 $650.00 | 6 | |
DRB is an adenosine analog that inhibits RNA polymerase II transcription, potentially reducing RBM4B mRNA synthesis. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $73.00 $238.00 $717.00 $2522.00 $21420.00 | 53 | |
Although previously mentioned for another protein, Actinomycin D binds to DNA and inhibits RNA synthesis, possibly affecting RBM4B expression. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $260.00 $1029.00 | 26 | |
α-Amanitin is a potent inhibitor of RNA polymerase II, which could hinder mRNA production including RBM4B. | ||||||
Homoharringtonine | 26833-87-4 | sc-202652 sc-202652A sc-202652B | 1 mg 5 mg 10 mg | $51.00 $123.00 $178.00 | 11 | |
Homoharringtonine is known to inhibit protein synthesis at the initiation step, which could reduce RBM4B protein levels indirectly. | ||||||
Cordycepin | 73-03-0 | sc-203902 | 10 mg | $99.00 | 5 | |
Cordycepin (3'-deoxyadenosine) inhibits RNA polymerase and thus could decrease RBM4B mRNA transcription. | ||||||
Olaparib | 763113-22-0 | sc-302017 sc-302017A sc-302017B | 250 mg 500 mg 1 g | $206.00 $299.00 $485.00 | 10 | |
Olaparib, a PARP inhibitor, may influence various cellular processes including transcription regulation, potentially affecting RBM4B expression. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $97.00 $254.00 | 36 | |
Anisomycin interferes with protein synthesis by inhibiting peptidyl transferase activity of the ribosome, which could reduce RBM4B levels. | ||||||